Your browser doesn't support javascript.
loading
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens.
Kalaora, Shelly; Barnea, Eilon; Merhavi-Shoham, Efrat; Qutob, Nouar; Teer, Jamie K; Shimony, Nilly; Schachter, Jacob; Rosenberg, Steven A; Besser, Michal J; Admon, Arie; Samuels, Yardena.
Afiliação
  • Kalaora S; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Barnea E; Department of Biology, Technion, Haifa, Israel.
  • Merhavi-Shoham E; The Ella Lemelbaum Institute for Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Qutob N; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Teer JK; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Shimony N; The Ella Lemelbaum Institute for Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Schachter J; The Ella Lemelbaum Institute for Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Rosenberg SA; National Cancer Institute, NIH, MD, USA.
  • Besser MJ; The Ella Lemelbaum Institute for Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Admon A; Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Samuels Y; Department of Biology, Technion, Haifa, Israel.
Oncotarget ; 7(5): 5110-7, 2016 Feb 02.
Article em En | MEDLINE | ID: mdl-26819371
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe I / Apresentação de Antígeno / Peptidomiméticos / Exoma / Antígenos de Neoplasias Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe I / Apresentação de Antígeno / Peptidomiméticos / Exoma / Antígenos de Neoplasias Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Israel